Hottest Stocks
(Over $10)
Hottest Stocks
($2-$10)
Biggest Losers
(Over $10)
Biggest Losers
($2-$10)
Hottest
Industries
Hottest
Sectors
EPS / Sales
Surprises
 
Enter Ticker Symbol:   Ticker Lookup
 

Enter any portion of the company’s name to find its corresponding ticker symbol:
Search for :   

Zacks Company Profile for Quanterix Corporation (QTRX : NSDQ)
 
 • Company Description   
Quanterix Corporation is a developer of tools in high definition diagnostics. The Company focuses on research and diagnostics for brain injuries, heart disease, cancer and other diseases with its technology. It offers Simoa consumables, which include Simoa Discs, Simoa Cuvettes, Simoa Sealing Oil, Simoa Buffers and Disposable Tips. The company services include Simoa Accelerator Lab and custom assay development services. Quanterix Corporation is based in LEXINGTON, United States.

Number of Employees: 460

 
 • Price / Volume Information   
Yesterday's Closing Price: $17.20 Daily Weekly Monthly
20 Day Moving Average: 347,794 shares
Shares Outstanding: 36.91 (millions)
Market Capitalization: $634.85 (millions)
Beta: 1.59
52 Week High: $69.22
52 Week Low: $14.86
Short Interest Ratio:
  % Price Change % Price Change Relative to S&P 500
4 Week -29.85% -21.00%
12 Week -44.57% -39.07%
Year To Date -59.43% -51.04%
 
 • Address & Contact Information
Street Address Phone / Fax Email Address Web URL
900 MIDDLESEX TURNPIKE
-
BILLERICA,MA 01821
USA
ph: 617-301-9400
fax: -
shrusovsky@quanterix.com http://www.quanterix.com
 
 • General Corporate Information   
Officers
E. Kevin Hrusovsky - Chairman and Chief Executive Officer
Michael A. Doyle - Chief Financial Officer
Keith L. Crandell - Director
Sarah E. Hlavinka - Director
Martin D. Madaus - Director

Peer Information
Quanterix Corporation (BJCT)
Quanterix Corporation (CADMQ)
Quanterix Corporation (APNO)
Quanterix Corporation (UPDC)
Quanterix Corporation (IMTIQ)
Quanterix Corporation (CYGN)
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: MED PRODUCTS
Sector: Medical
CUSIP: 74766Q101
SIC: 3826
Fiscal Year
Fiscal Year End: December
Last Reported Quarter: 03/01/22
Next Expected EPS Date: 08/04/22
Share - Related Items
Shares Outstanding: 36.91
Most Recent Split Date: (:1)
Beta: 1.59
Market Capitalization: $634.85 (millions)
 
 
 • EPS Information     • Dividend Information
Analyst Coverage: No Dividend Yield: 0.00%
Current Fiscal Quarter EPS Consensus Estimate: $-0.67 Indicated Annual Dividend: $0.00
Current Fiscal Year EPS Consensus Estimate: $-2.49 Payout Ratio:
Number of Estimates in the Fiscal Year Consensus: 1.00 Change In Payout Ratio:
Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00
Next EPS Report Date: 08/04/22  
 

 • Fundamental Ratios
P/E
Current FY Estimate: -
Trailing 12 Months: -
PEG Ratio: -
Price Ratios
Price/Book: 1.49
Price/Cash Flow: -
Price / Sales: 5.62
EPS Growth
vs. Year Ago Period: -68.97%
vs. Previous Quarter: 10.91%
Sales Growth
vs. Year Ago Period: 8.61%
vs. Previous Quarter: -2.43%
ROE
03/31/22 - -14.70
12/31/21 - -12.58
09/30/21 - -11.88
ROA
03/31/22 - -12.86
12/31/21 - -11.13
09/30/21 - -10.31
Current Ratio
03/31/22 - 13.65
12/31/21 - 12.14
09/30/21 - 14.73
Quick Ratio
03/31/22 - 12.94
12/31/21 - 11.54
09/30/21 - 14.00
Operating Margin
03/31/22 - -58.23
12/31/21 - -52.18
09/30/21 - -44.63
Net Margin
03/31/22 - -58.23
12/31/21 - -52.18
09/30/21 - -44.63
Pre-Tax Margin
03/31/22 - -58.40
12/31/21 - -52.21
09/30/21 - -44.71
Book Value
03/31/22 - 11.55
12/31/21 - 12.03
09/30/21 - 12.47
Inventory Turnover
03/31/22 - 2.38
12/31/21 - 2.35
09/30/21 - 2.42
Debt-to-Equity
03/31/22 - 0.00
12/31/21 - 0.00
09/30/21 - 0.00
Debt-to-Capital
03/31/22 - 0.00
12/31/21 - 0.00
09/30/21 - 0.00
 

Powered by Zacks Investment Research ©